Browsing by Author "Bley, Annette"
Now showing 1 - 7 of 7
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settingsCorrection to: Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus–Merzbacher disease(2019)
;Stumpf, Sina K. ;Berghoff, Stefan A.; ;Spieth, Lena ;Düking, Tim ;Schneider, Lennart V. ;Schlaphoff, Lennart; ;Bley, Annette ;Burfeind, Dinah; ;Mitkovski, Miso ;Ruhwedel, Torben ;Guder, Philipp ;Röhse, Heiko ;Denecke, Jonas; ; ; Saher, Gesine - Some of the metrics are blocked by yourconsent settingsImaging evidence of early brain tissue degeneration in patients with vanishing white matter disease: A multimodal MR study(Wiley-blackwell, 2012)
;Ding, Xiao-Qi ;Bley, Annette; ;Kohlschuetter, Alfried ;Fiehler, Jens ;Zhu, W.Lanfermann, HeinrichTo find imaging signs of active degenerative processes in vanishing white matter disease (VWM), six VWM patients and six matched controls underwent MR examinations. The data were analyzed with modified Scheltens scales for morphological findings and determined quantitatively for apparent diffusion coefficient (ADC). Single-voxel MR spectra were acquired at the parietal white matter and analyzed with LCModel. Typical VWM brain lesions were found in all patients accompanied by proton diffusion abnormalities: Increased ADC appeared in brain regions with severe myelin destruction in all patients, and reduced ADC in two of six younger patients in remaining white matter adjacent to the lesions or at the borders around the lesions, who had a short history of the disease (= 1 year). The MR spectroscopy revealed reductions of NAA, Cho, and Cr, which correlate to the grade of white matter abnormalities. An increase of myo-inositol as marker of reactive gliosis was missing. Thus, restricted proton diffusion was evident in younger VWM patients with short history of disease, which in combination with lack of reactive gliosis may reflect early white matter degeneration in VWM. The multimodal MR methods are useful for characterizing such tissue degeneration in brain in vivo. J. Magn. Reson. Imaging 2012;35:926932. (c) 2011 Wiley Periodicals, Inc. - Some of the metrics are blocked by yourconsent settingsKetogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus-Merzbacher disease(2019)
;Stumpf, Sina K. ;Berghoff, Stefan A.; ;Spieth, Lena ;Düking, Tim ;Schneider, Lennart V. ;Schlaphoff, Lennart; ;Bley, Annette ;Burfeind, Dinah; ;Mitkovski, Miso ;Ruhwedel, Torben ;Guder, Philipp ;Röhse, Heiko ;Denecke, Jonas; ; ; Saher, GesinePelizaeus-Merzbacher disease (PMD) is an untreatable and fatal leukodystrophy. In a model of PMD with perturbed blood-brain barrier integrity, cholesterol supplementation promotes myelin membrane growth. Here, we show that in contrast to the mouse model, dietary cholesterol in two PMD patients did not lead to a major advancement of hypomyelination, potentially because the intact blood-brain barrier precludes its entry into the CNS. We therefore turned to a PMD mouse model with preserved blood-brain barrier integrity and show that a high-fat/low-carbohydrate ketogenic diet restored oligodendrocyte integrity and increased CNS myelination. This dietary intervention also ameliorated axonal degeneration and normalized motor functions. Moreover, in a paradigm of adult remyelination, ketogenic diet facilitated repair and attenuated axon damage. We suggest that a therapy with lipids such as ketone bodies, that readily enter the brain, can circumvent the requirement of a disrupted blood-brain barrier in the treatment of myelin disease. - Some of the metrics are blocked by yourconsent settingsLanguage and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort(Biomed Central Ltd, 2014)
;Kehrer, Christiane ;Groeschel, Samuel ;Kustermann-Kuhn, Birgit ;Buerger, Friederike ;Koehler, Wolfgang ;Kohlschuetter, Alfried ;Bley, Annette; ;Gieselmann, VolkmarKraegeloh-Mann, IngeborgBackground: Metachromatic leukodystrophy (MLD) is a rare, genetic neurodegenerative disease. It leads to progressive demyelination resulting in regression of development and early death. With regard to experimental therapies, knowledge of the natural course of the disease is highly important. We aimed to analyse onset and character of first symptoms in MLD and to provide detailed natural course data concerning language and cognition. Methods: Patients with MLD were recruited nationwide within the scope of the German research network LEUKONET. 59 patients' questionnaires (23 late-infantile, 36 juvenile) were analysed. Results: Time from first symptoms (at a median age of 1.5 years in late-infantile and 6 years in juvenile MLD) to diagnosis took one year in late-infantile and two years in juvenile patients on average. Gait disturbances and abnormal movement patterns were first signs in all patients with late-infantile and in most with juvenile MLD. Onset in the latter was additionally characterized by problems in concentration, behaviour and fine motor function (p = 0.0011, p < 0.0001, and p = 0.0012). Half of late-infantile patients did not learn to speak in complete sentences after an initially normal language acquisition. They showed a rapid language decline with first language difficulties at a median age of 2.5 years and complete loss of expressive language within several months (median age 32, range 22-47 months). This was followed by total loss of communication at a median age of around four years. In juvenile patients, language decline was more protracted, and problems in concentration and behaviour were followed by decline in skills for reading, writing and calculating around four years after disease onset. Conclusions: Our data reflect the natural course of decline in language and cognition in late-infantile and juvenile MLD in a large cohort over a long observation period. This is especially relevant to juvenile patients where the disease course is protracted and prospective studies are hardly feasible. Knowledge of first symptoms may lead to earlier diagnosis and subsequently to a better outcome following therapeutic intervention. Our data may serve as a reference for individual treatment decisions and for evaluation of clinical outcome after treatment intervention. - Some of the metrics are blocked by yourconsent settingsLeukodystrophies and other genetic metabolic leukoencephalopathies in children and adults(Elsevier Science Bv, 2010)
;Kohlschuetter, Alfried ;Bley, Annette; ; ;Kraegeloh-Mann, Ingeborg ;Rolfs, ArndtSchoels, LudgerAbnormalities of CNS white matter are frequently detected in patients with neurological disorders when MRI studies are performed. Among the many causes of such abnormalities, a large group of rare genetic diseases poses considerable diagnostic problems. Here we present a compilation of genetic leukoencephalopathies to consider when one is confronted with white matter disease of possibly genetic origin. The table contains essentials such as age at onset of symptoms, clinical and MRI characteristics, basic defect, and useful diagnostic studies. The table serves as a diagnostic check list. (C) 2009 Elsevier B.V. All rights reserved. - Some of the metrics are blocked by yourconsent settingsMetachromatic leukodystrophy: natural course of cerebral MRI changes in relation to clinical course(Springer, 2011)
;Groeschel, Samuel ;Kehrer, Christiane ;Engel, Corinna ;Dali, Christine I. ;Bley, Annette; ;Grodd, WolfgangKraegeloh-Mann, IngeborgObjective Metachromatic Leukodystrophy (MLD) is a rare disorder leading to demyelination and neurological impairment. A natural history study within the German leukodystrophy network analyzed MRI changes with respect to the clinical course. Methods 113 MR images of 68 patients (33 late-infantile, 35 juvenile) were studied cross-sectionally and longitudinally. MRI and motor deterioration were assessed using standardized scoring systems. Results The temporal and spatial patterns of MR severity scores differed between the late-infantile and juvenile form. Although early (involving central white matter, corpus callosum) and late signs (involving pons, cerebellum, cerebral atrophy) were similar, high MRI scores (mean 18, SD 1.2, p<0.001) were evident in the juvenile form already at the onset of first symptoms and even in presymptomatic patients. The progression rate of the MRI score was clearly higher and more uniform in the late-infantile (on average 8 per year, p<0.0001) than in the juvenile patients (on average 0.4 per year, p<0.08). In late-infantile patients, MRI changes correlated highly with motor deterioration (rho=0.73, p<0.001), this was less remarkable in the juvenile form (rho=0.50, p<0.01). Severe motor dysfunction was associated with U-fiber involvement and cerebellar changes (p<0.05). Conclusions MRI showed a typical spatial pattern, which evolved gradually and uniformly during disease progression in late-infantile MLD. In juvenile MLD MRI changes were already observed at disease onset and temporal patterns were more variable. As therapeutic options for MLD are evolving, these findings are not only important for patient counseling but also for the evaluation of therapeutic interventions. - Some of the metrics are blocked by yourconsent settingsUse of monoclonal antibodies to assess expression of anaphylatoxin receptors in tubular epithelial cells of human, murine and rat kidneys(Elsevier Gmbh, Urban & Fischer Verlag, 2007)
;Kiafard, Ziba ;Tschernig, Thomas ;Schweyer, Stefan ;Bley, Annette ;Neumannd, DetlefZwirner, JoergTo assess published evidence of anaphylatoxin receptor expression in renal tubular epithelia] cells, monoclonal antibodies (mAbs) against human, mouse and rat receptors for C5a and C3a (C5aR, C3aR) were raised using receptor-expressing transfectants as immunogens. Applying these reagents in immunohistochemistry, we observed that mAbs with reactivities against three distinct epitopes of human C5aR N-terminus recognized tissue macrophages but not at all renal tubular epithelial cells. These findings were surprising, as strong tubular staining had been previously demonstrated by mAbs raised against a synthetic N-terminal C5aR peptide. To extend our study to mammalian kidneys, renal specimens from normal rats as well as LPS-treated Balb/c and MRL/1pr mice, which suffered from lupus-type nephritis, were examined. Similar to humans, mAbs against murine or rat C5aR strongly recognized infiltrating leukocytes in situ whereas tubular epithelial cells remained negative. As a mAb has been previously used to document C3aR expression in renal tubular epithelia] cells, kidney specimens were examined using newly established mAbs against different epitopes of human, murine and rat C3aR. In contrast to published evidence, C3aR was detectable exclusively in interstitial leukocytes but not in epithelia] tubular cells of normal and diseased tissues. Taken together, our findings question a direct involvement of tubular epithelial cells in anaphylatoxin-mediated renal inflammation. Furthermore, as we demonstrate in the case of anaphylatoxin receptors, cross-reactivities of mAbs may constitute as yet underestimated pitfalls in immunohistochemical antigen detection. (c) 2006 Elsevier GmbH. All rights reserved.